Normal delivery following use of galcanezumab until the first and second trimesters of pregnancy: A report of 2 cases

The safety of galcanezumab administration in pregnant women has only been reported in scattered case reports, and further case studies are needed. It is considered necessary to continue to monitor newborns for the development of neurological abnormalities, including higher brain functions.